Moglia Stephen A.

VP & Chief Accounting Officer at Orexigen Therapeutics, Inc.

Sold, on record
$2k
Dollars the filings state
Form 4 sales
2
Latest Mar 15, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Dec 19 2016

    Sold 800 shares at $1.96 ($2k)

    Moglia Stephen A., VP, Chief Accounting Officer

    Sold 100% of holdings ($2k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Mar 15 +451 days

    Sold 1,694 shares at $0.24 ($407)

    Moglia Stephen A., VP & Chief Accounting Officer

    Sold 100% of holdings ($407 position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Moglia Stephen A.
Source
Mar 15, 2018Orexigen Therapeutics, Inc.VP & Chief Accounting OfficerForm 4 sale1,694$407100.0%UnusualSEC
Dec 19, 2016Orexigen Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale800$2k100.0%UnusualSEC